Streetbeat News

Stock Prices

NVDA

Nvidia Corp (NASDAQ:NVDA) has seen a significant rise, with a 245% increase through 2023 and an additional 80% in 2024, amid the AI-driven stock surge. BofA Securities analyst Vivek Arya maintains a Buy rating on NVDA, raising the price target from $925 to $1,100, indicating a 28.2% upside. Arya highlights Nvidia's central role in the AI landscape and its potential for growth, especially with genAI expected to double the data center market to $2 trillion. Despite a current dip in NVDA's stock price, Arya sees untapped upside potential.

Portfolio Pulse from Surbhi Jain

March 13, 2024 | 4:19 pm

ACDC

ProFrac Holding Corp. (NASDAQ:ACDC) shares fell after reporting Q4 FY23 results with revenue of $489 million missing estimates of $594.97 million and a net loss of $99.1 million compared to a net income of $40.9 million in the prior year. Adjusted EBITDA also declined to $110 million from $263.4 million. Despite this, the company anticipates higher profitability in 2024, especially in the Stimulation Services segment and expects modest improvement in the Proppant Production segment.

Portfolio Pulse from Lekha Gupta

March 13, 2024 | 4:17 pm

SNOW

Recent options trading trends for Snowflake (NYSE:SNOW) show a bearish sentiment among investors, with 58% of trades being bearish. Significant trading activity has targeted a price range of $115.0 to $195.0. Despite this, expert analysts have set higher target prices for SNOW, ranging from $214 to $290. The company's current market performance shows a slight decrease in stock price to $161.6, with an indication of being potentially oversold. Snowflake's next earnings report is expected in 70 days.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:16 pm

IOVA

Recent options trading activity in Iovance Biotherapeutics (NASDAQ:IOVA) indicates a bearish stance by big-money investors, with a split sentiment of 37% bullish and 62% bearish. The options scanner revealed 8 unusual trades, with a price target window from $7.5 to $30.0. Analysts have issued ratings with a consensus target price of $24.6, despite the stock's slight decline and potential overbought status. The company is preparing for potential U.S. regulatory approvals and commercialization of its tumor-infiltrating lymphocyte therapies.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:16 pm

KB

KB Financial shares are trading higher due to recent strength in Korean stocks.

Portfolio Pulse from Benzinga Newsdesk

March 13, 2024 | 4:14 pm

GIII

G-III Apparel Group (NASDAQ:GIII) is expected to report an EPS of $0.67 in its upcoming quarterly earnings on March 14, 2024. Historically, the company has had mixed reactions to its earnings reports, with share prices fluctuating post-announcement. Over the last year, GIII shares have surged by 99.02%, indicating a bullish sentiment among long-term investors. Analysts and investors will be closely watching the company's performance and future guidance.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:01 pm

MOMO

Hello Gr (NASDAQ:MOMO) is scheduled to release its quarterly earnings report on March 14, 2024, with an expected EPS of $0.34. Historical data shows mixed reactions to past earnings, with the last quarter beating estimates but not affecting the stock price. Shares are currently trading at $7.45, down 0.65% over the last year. Investors are looking for positive guidance for future growth.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:01 pm

ZUMZ

Zumiez (NASDAQ:ZUMZ) is anticipated to report a quarterly EPS of $0.26 on March 14, 2024. Historical data shows varied stock price reactions to past earnings performances, with a notable 11.97% increase after last quarter's beat. Shares have declined 17.4% over the past year, indicating potential investor concern ahead of this release.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:01 pm

LZ

Four analysts have recently updated their ratings on LegalZoom.com (NASDAQ:LZ), with all maintaining a somewhat bullish stance. The average 12-month price target is now $14.25, down from $16.00, indicating a 10.94% decrease. LegalZoom.com has shown solid financial performance, with notable revenue growth and strong financial health indicators such as net margin, ROE, and ROA. The company's market capitalization is below industry benchmarks, but it has a low debt-to-equity ratio, suggesting a sound financial structure.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:01 pm

TLYS

Tilly's (NYSE:TLYS) is scheduled to release its quarterly earnings report on March 14, 2024, with an expected EPS of $-0.22. Investors are hopeful for a beat on this estimate and positive future guidance. Historical data shows mixed reactions in stock price to past earnings performances, with shares currently down 4.72% over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

March 13, 2024 | 4:01 pm